Gilead Lures Roche Pharma CEO O'Day As CEO; Genentech's CEO Will Replace Him

 
• By Sten Stovall

O'Day brings Gilead experience in oncology and M&A from a large, diversified organization.

Daniel O Day
O'Day Seen Bringing Valuable M&A, Oncology Experience To Gilead

More from Executives On The Move

More from Leadership